OBJECTIVES: To summarize the pharmacoeconomics research articles published on diabetes and hypertension in India. METHODS: A PubMed database was searched for pharmacoeconomics research on diabetes and hypertension in India. The articles that were published and were available on Pubmed database from the year 1990 to 2014 were searched by using MeSH (Medical Subject Headings) terms viz., pharmacoeconomics, cost effective analysis, cost analysis, health care cost, economic analysis and cost of illness. All the studies shown in the search results were considered for the study irrespective of the type of pharmacoeconomic evaluation. RESULTS: A total of 446 pharmacoeconomics research articles were found based on the MeSH terms. Out of 446, 15 (68.18%) studies were related to diabetes and 7 (31.82%) studies were related to hypertension. In India, most of the studies were conducted in Tamil Nadu state (n=12, 54.54%) followed by Karnataka (n=2, 9.09%), Chandigarh (n=2, 9.09%), Kerala (n=2; 9.09%), New Delhi (n=1, 4.54%), Maharashtra (n=1, 4.54%), Gujarat (n=1, 4.54%) and Telangana state (n=1, 4.54%). Most of the articles were published in between the year 2011-2014 (n=10, 45.45%) followed by 2007-2010 (n=6, 27.27%) and 2000-2002 (n=6, 27.27%). There were no published articles on pharmacoeconomic studies from the year 2003 to 2006. CONCLUSIONS: The pharmacoeconomic studies published in India are relatively less compared to that of developed countries. There is a need for furthering pharmacoeconomic research on the most prevalent chronic diseases such as diabetes and hypertension in India. Researchers should also gear-up to publish pharmacoeconomics related research in reputed journals with high impact factor.